Risk of Revision Following Knee Arthroplasty in Bariatric Surgery Patients
- Conditions
- Prosthesis FailureProsthesis SurvivalBariatric Surgery CandidateProsthesis-Related InfectionsArthritis Knee
- Interventions
- Other: BASOther: Non-BAS
- Registration Number
- NCT06433700
- Lead Sponsor
- Bispebjerg Hospital
- Brief Summary
Previous studies have investigated the outcomes of Knee Arthroplasty (KA) following Bariatric Surgery (BAS), but with substantial limitations as not stratifying for Body Mass Index (BMI) at time of KA or not addressing the type of BAS (gastric bypass, banding or sleeve). Since BMI varies greatly in patients with previous BAS, it is likely that BMI affects outcomes after KA in BAS-operated patients.
The investigators believe that stratifying for BMI would explain the contradictions with the previous research in this patient group when it comes to the risk of revision after KA.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 90000
- Primary knee arthroplasty due to osteoarthritis
- Primary knee arthroplasty due to traumatic osteoarthritis.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description BAS group BAS Patients who received bariatric surgery prior to their knee arthroplasty Non-BAS group Non-BAS Patients who did not receive bariatric surgery prior to their knee arthroplasty
- Primary Outcome Measures
Name Time Method Hazard rate of Revision due to any cause within 90 days and within 2 years Revision surgery is defined as surgery with debridement and/or exchange of at least one component
Hazard rate of Revision due to infection within 90 days and within 2 years Our definition of infection is adapted from the European Bone and Joint Infection Society (EBJIS) criteria as at least one of the following A. An indication of deep infection is reported to the Danish knee arthroplasty register (DKR) by the surgeon on revision surgery B. At least 2 deep-tissue samples of phenotypically indistinguishable bacteria isolated from at least 3 deep-tissue samples C. One or more positive intraoperative samples from a closed fluid aspirate AND a biopsy (fluid AND tissue) of phenotypically indistinguishable bacteria isolated.
- Secondary Outcome Measures
Name Time Method Mortality 2 years postoperatively Mortality registered in the Danish Civil Registration System (DCRS) by date
Hazard rate of Knee related antibiotic use within 30- and 90-days following KA within 30- and 90-days following KA the use of one of the following oral antibiotics: dicloxacillin, flucloxacillin, phenoxymethylpenicillin, amoxicillin, oral ciprofloxacin, roxithromycin, linezolid, cefuroxime and cefalexin
Hazard rate of Antibiotic use due to other causes within 30- and 90-days following KA the use of one of oral antibiotics other than those that were mentioned in outcome 3.
Trial Locations
- Locations (1)
Orthopaedic department, Bispebjerg Hospital
🇩🇰Copenhagen, Denmark